The proportion of CD3- CD4+ T-cell population remained unaffected after corticosteroids treatment for lymphocytic variant hypereosinophilic syndrome (L-HES)

Scandinavian Journal of Immunology

Volumn 72, Issue 4, 2010, Pages 372-373

  Helbig, G ^a   Wichary, R ^a   Razny, M ^b   Rodzaj, M ^b   Wozniczka, K ^a   Dziaczkowska Suszek, J ^a   Kyrcz Krzemien, S ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b Provincial Hospital   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E; INTERLEUKIN 4; INTERLEUKIN 5; PREDNISONE; T LYMPHOCYTE RECEPTOR BETA CHAIN; T LYMPHOCYTE RECEPTOR DELTA CHAIN; T LYMPHOCYTE RECEPTOR GAMMA CHAIN; CD3 ANTIGEN; GLUCOCORTICOID;

ADULT; BLOOD; CD3- CD4+ T LYMPHOCYTE; CELL POPULATION; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; FEMALE; FLOW CYTOMETRY; HUMAN; HYPEREOSINOPHILIA; HYPEREOSINOPHILIC SYNDROME; IMMUNOPHENOTYPING; LETTER; LEUKOCYTOSIS; LYMPHOCYTIC VARIANT HYPEREOSINOPHILIC SYNDROME; MALE; PRIORITY JOURNAL; T LYMPHOCYTE; TREATMENT OUTCOME; CASE REPORT; CD4+ T LYMPHOCYTE; DRUG EFFECTS; IMMUNOLOGY; LYMPHOCYTE COUNT; METABOLISM;

ADULT; ANTIGENS, CD3; CD4-POSITIVE T-LYMPHOCYTES; FLOW CYTOMETRY; GLUCOCORTICOIDS; HUMANS; HYPEREOSINOPHILIC SYNDROME; LYMPHOCYTE COUNT; MALE; PREDNISONE;

EID: 77956333672     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2010.02436.x     Document Type: Letter

References (13)

1. Roufosse F. Hypereosinophilic syndrome variants: diagnostic and therapeutic considerations. Haematologica 2009 94 : 1188 1192.
2. Ogbogu PU, Bochner BS, Butterfield JH et al. Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy. J Allergy Clin Immunol 2009 124 : 1319 1325.
3. Simon UW, Plotz SG, Dummer R, Blaser K. Abnormal clones of T cells producing interleukin-5 in idiopathic eosinophilia. N Engl J Med 1999 341 : 1112 1120.
4. Helbig G, Wieczorkiewicz A, Dziaczkowska-Suszek J, Majewski M, Kyrcz-Krzemień S. T-cell abnormalities are present at high frequencies in patients with hypereosinophilic syndrome. Haematologica 2009 94 : 1236 1241.
5. Helbig G, Moskwa A, Hus M et al. Heterogeneity among characteristics of hypereosinophilic syndromes. J Allergy Clin Immunol 2010 doi.org/.
6. van Dongen JJ, Langerak AW, Bruggemann M et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia, 2003 17 : 2257 2317.
7. Braun CM, Huang SK, Bashian GG et al. Corticosteroid modulation of human, antigen-specific Th1 and Th2 responses. J Allergy Clin Immunol 1997 100 : 400 407.
8. Simon UW. Eosinophil apoptosis: pathophysiologic and therapeutic implications. Allergy 2000 55 : 910 915.
9. Roufosse F, Cogan E, Goldman M. Lymphocytic Variant Hypereosinophilic Syndromes. Immunol Allergy Clin North Am 2007 27 : 389 413.
10. Roufosse F, Schandene L, Sibille C et al. Clonal Th2 lymphocytes in patients with the idiopathic hypereosinophilic syndrome. Br J Haematol 2000 109 : 540 548.
11. Brugnoni D, Airo P, Rossi G et al. A case of Hypereosinophilic Syndrome is associated with the expansion of a CD3-CD4+ T-cell population able to secrete large amounts of interleukin-5. Blood 1996 87 : 1416 1422.
12. Bank I, Amariglio N, Reshef A et al. The hypereosinophilic syndrome associated with CD4+ CD3- helper type 2 (Th2) lymphocytes. Leuk Lymphoma 2001 42 : 123 133.
13. Rothenberg ME, Klion AD, Roufosse FE et al. Treatment of patients with the hypereosinophilic syndrome with mepolizumab. N Engl J Med 2008 358 : 1215 1228.